OFFICIAL PUBLICATION OF

by its subsidiary APPco

Arrotex bolsters pharmacy offering

Sheshtyn Paola 06/02/2020

Following the merger of Apotex and Arrow, the combined Arrotex entity now has a considerable portfolio of respiratory medicines – including two new products Arrotex Pharmaceuticals has announced a strategic partnership with Boehringer Ingelheim for the exclusive Australian reseller rights to respiratory products Spiriva (tiotropium 18 micrograms powder for inhalation) and Spiriva HandiHaler, both used

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Thank you’: How I saved a patient’s life with naloxone

You are right Adam it is absorbed orally and undergoes extensive first pass . Contraindicated in hepatic disease .

Michael Post

Patients back scope expansion

Ben, Hx and exam is a minimum 4 year medical degree. It takes many years of tertiary experience to learn…

Michael Post

CWH founders building a business for their ‘kids and grandkids’

“We need to move from a non-sophisticated business model to one with corporate governance. ... see that , I don't…

Ahmad Hawwari

CWH founders building a business for their ‘kids and grandkids’

Mmm doubt that , if CWH continue like this more influential people will have interest to lobby the government as…

Ahmad Hawwari

Arrotex bolsters pharmacy offering

Previous World news wrapup: 6 February 2020

Next Delving into the opioid epidemic

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous World news wrapup: 6 February 2020

Next Delving into the opioid epidemic

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.